Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tamoxifen oral liquid - Rosemont Pharmaceuticals

Next Previous
X
Search
Drug Profile

Tamoxifen oral liquid - Rosemont Pharmaceuticals

Alternative Names: Soltamox; Tamoxifen citrate; Tamoxifen oral liquid solution - Rosemont Pharmaceuticals

Latest Information Update: 17 Dec 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rosemont Pharmaceuticals Ltd; University of Birmingham
  • Developer Rosemont Pharmaceuticals Ltd
  • Class Antineoplastics; Chemopreventatives; Dimethylamines; Infertility therapies; Phenyl ethers; Small molecules; Stilbenes
  • Mechanism of Action Estrogen receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer

Most Recent Events

  • 13 Nov 2018 Midatech Pharma US has been acquired by Kanwa Holdings
  • 06 Jan 2015 DARA Biosciences receives product and establishment fee waiver from the FDA
  • 29 Oct 2014 DARA BioSciences files a petition with US FDA for a label update for Tamoxifen oral liquid as an adjuvant therapy for breast cancer, from five to ten years .

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top